Biomedical subjects
Publications and source records attributed to S Baggio.
The structure of the title compound, [Mn(tpy)2](S4O6)*3H2O (tpy is 2,2':6',2"-terpyridine, C15H11N3), consists of monomeric [Mn(tpy)2]2+ units embedded in a complex anionic network made up of tetrathionate ions and hydration water molecules connected via a complex hydrogen-bonding scheme.
The structure of the title compound, [Ni(NO(3))(C(18)H(12)N(2))(H(2)O)(2)]NO(3) x H(2)O, is composed of monomers with the nickel ion octahedrally coordinated to a bidentate biquinoline ligand, a bidentate nitrate anion and two water molecules, and is stabilized by a nitrate counter-ion and a hydrate water molecule. There is a fairly complex hydrogen-bonding scheme involving all the water H atoms and five different nitrate O atoms.
Three cis nickel-dithiocyanate (SCN) complexes with different N,N'-bidentate bases have been prepared and their crystal structures determined: bis(2,2'-bipyridine-N,N')bis(-ato-N)nickel(II), [Ni(SCN)(2)(C(10)H(8)N(2))(2)], bis(1,10-phenanthroline-N,N')bis(thiocyanato-N)nickel(II), [Ni(SCN)(2)(C(12)H(8)N(2))(2)], and bis(2,9-dimethyl-1,10-phenanthroline-N,N')bis(thiocyanato-N)nickel(II) monohydrate, [Ni(SCN)(2)(C(12)H(8)N(2))(2)].H(2)O. Distortions due to ligand size are discussed.
The structures of [Mn(S2O3)2(C12H8N2)(H2O(2)] and [Mn(S4O6)(C10H8N2)(2)] are presented. The former consists of pairs of polymeric chains formed by manganese polyhedra bridged by bidentate thiosulfate anions, which are in turn related to each other by a pseudo-twofold screw axis. The latter has crystallographic twofold symmetry and consists of monomers in which manganese displays its typical octahedral coordination provided by the bidentate bites of two bipyridine bases and a tetrathionate anion, which is, to our knowledge, the first chelating tetrathionate to be reported in the literature.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The title compounds, [Ni(S(2)O(3))(C(12)H(8)N(2))(2)].0.92H(2)O.1. 4CH(4)O and [Ni(S(2)O(3))(C(10)H(8)N(2))(2)].2H(2)O.0.55CH(4)O, are monomeric, containing nickel(II) in a distorted octahedral coordination environment provided by the four N atoms of two bidentate bipy or phen groups and one S and one O atom from a chelating thiosulfate anion. The crystals are highly unstable outside their mother liquors and are stabilized in solution by a not fully determined number of water and methanol solvate molecules. The phenanthroline structure includes two independent moieties related by a non-crystallographic inversion center. The thiosulfate anions display the usual S-O lengthening found when the anion acts in a bidentate mode.
The beneficial effects of physical exercise on the blood pressure are widely recognised. Nevertheless, some athletes remain hypertensive and the treatment of this population makes special demands with respect to treatment efficacy and tolerability, the respect of athletic performance and problems of proscribed substances. For example, the Athletic Boards have prohibited betablockers and diuretics in competitive athletes. The aim of this study was to assess nicardipine LA 50 mg administered twice daily in the special context of hypertensive athletes. Thirty-eight athletes with mild or moderate hypertension undergoing endurance training were included in this double blind trial versus placebo. After two months treatment, the systolic and diastolic blood pressures were significantly lower at rest in the nicardipine than in the placebo group (delta SBP = -18.9 vs -4.1 mmHg, p less than 0.001; delta DBP = -15.7 vs -4.1 mmHg, p less than 0.01). In addition the maximum SBP on effort was significantly lower in the nicardipine group (200 vs 215 mmHg, p less than 0.05). On the other hand, no difference was observed between the two groups as regards the maximum oxygen consumption (delta VO2 max = 6.2 vs -0.4 ml/min/kg, NS) and duration of effort (13.75 vs 12.32 min, NS), showing that athletic performance was unchanged in the group treated by nicardipine LA. These results suggest that treatment with nicardipine LA fulfills the special criteria of hypertensive athletes.
Explore the source record for details and available documents.